BR0017366A - Detecção de agentes infecciosos usando imitadores de antìgeno - Google Patents
Detecção de agentes infecciosos usando imitadores de antìgenoInfo
- Publication number
- BR0017366A BR0017366A BR0017366-5A BR0017366A BR0017366A BR 0017366 A BR0017366 A BR 0017366A BR 0017366 A BR0017366 A BR 0017366A BR 0017366 A BR0017366 A BR 0017366A
- Authority
- BR
- Brazil
- Prior art keywords
- antigen
- detection
- infectious agents
- antibody
- binding
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IT2000/000442 WO2002037115A1 (en) | 2000-11-03 | 2000-11-03 | Detection of infectious agents using antigen mimics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0017366A true BR0017366A (pt) | 2004-06-15 |
Family
ID=11133576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0017366-5A BR0017366A (pt) | 2000-11-03 | 2000-11-03 | Detecção de agentes infecciosos usando imitadores de antìgeno |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1332369A1 (pl) |
| JP (1) | JP2004513346A (pl) |
| KR (1) | KR20030084895A (pl) |
| CN (1) | CN1455866A (pl) |
| AU (1) | AU2001218836A1 (pl) |
| BR (1) | BR0017366A (pl) |
| CA (1) | CA2427602A1 (pl) |
| HU (1) | HUP0302103A3 (pl) |
| MX (1) | MXPA03003794A (pl) |
| PL (1) | PL364832A1 (pl) |
| SK (1) | SK5362003A3 (pl) |
| WO (1) | WO2002037115A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2108656A1 (en) | 2008-03-19 | 2009-10-14 | Beninati, Concetta | Antigenic protein fragments of streptococcus pneumoniae |
| WO2009158682A2 (en) * | 2008-06-27 | 2009-12-30 | Watkinson D Tobin | Compositions and methods for diagnosing and treating pathogenic disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2172305A1 (en) * | 1995-03-30 | 1996-10-01 | Muneo Aoyama | Multiple antigenic peptide comprising at least two hepatitis c virus-associated peptides |
| AU3714499A (en) * | 1998-05-14 | 1999-11-29 | Pasteur Merieux Serums Et Vaccins | Hepatitis c virus mimotopes |
-
2000
- 2000-11-03 JP JP2002539818A patent/JP2004513346A/ja active Pending
- 2000-11-03 HU HU0302103A patent/HUP0302103A3/hu unknown
- 2000-11-03 PL PL00364832A patent/PL364832A1/pl unknown
- 2000-11-03 WO PCT/IT2000/000442 patent/WO2002037115A1/en not_active Ceased
- 2000-11-03 EP EP00981607A patent/EP1332369A1/en not_active Withdrawn
- 2000-11-03 BR BR0017366-5A patent/BR0017366A/pt not_active IP Right Cessation
- 2000-11-03 SK SK536-2003A patent/SK5362003A3/sk not_active Application Discontinuation
- 2000-11-03 CA CA002427602A patent/CA2427602A1/en not_active Abandoned
- 2000-11-03 CN CN00820000A patent/CN1455866A/zh active Pending
- 2000-11-03 MX MXPA03003794A patent/MXPA03003794A/es not_active Application Discontinuation
- 2000-11-03 AU AU2001218836A patent/AU2001218836A1/en not_active Abandoned
- 2000-11-03 KR KR10-2003-7006153A patent/KR20030084895A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004513346A (ja) | 2004-04-30 |
| CA2427602A1 (en) | 2002-05-10 |
| EP1332369A1 (en) | 2003-08-06 |
| PL364832A1 (pl) | 2004-12-27 |
| HUP0302103A3 (en) | 2007-03-28 |
| MXPA03003794A (es) | 2004-10-15 |
| HUP0302103A2 (hu) | 2003-09-29 |
| WO2002037115A1 (en) | 2002-05-10 |
| CN1455866A (zh) | 2003-11-12 |
| AU2001218836A1 (en) | 2002-05-15 |
| SK5362003A3 (en) | 2003-09-11 |
| KR20030084895A (ko) | 2003-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chia et al. | Serological differentiation between COVID-19 and SARS infections | |
| BRPI0111731C1 (pt) | suporte sólido de imunoensaio, métodos de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e de produção de um suporte sólido de imunoensaio, e, kit de teste de imunodiagnóstico | |
| TR200000113T2 (tr) | Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri. | |
| TW200512457A (en) | Method of diagnosing SARS corona virus infection | |
| Lee et al. | Increased detection of hepatitis C virus infection in commercial plasma donors by a third‐generation screening assay | |
| CN108333344A (zh) | 高灵敏度的化学发光免疫分析试剂盒及其制备方法和应用 | |
| Emmerich et al. | Longitudinal detection of SARS‐CoV‐2‐specific antibody responses with different serological methods | |
| BR0200986A (pt) | Ensaio de combinação anticorpo - antìgeno da hepatite c para a detecção precoce da infecção | |
| Pang et al. | Bioscreening specific peptide-expressing phage and its application in sensitive dual-mode immunoassay of SARS-CoV-2 spike antigen | |
| DE60234015D1 (de) | Latentes tuberkulose-diagnostisches antigen und verwendungsmethode | |
| BR0017366A (pt) | Detecção de agentes infecciosos usando imitadores de antìgeno | |
| DE602005009819D1 (de) | Verfahren zum nachweis von infektionen mit mykobakterien | |
| Deshpande et al. | Unveiling the quest: crafting an enzyme-linked immunosorbent assay (ELISA) technique to uncover COVID-19 antibodies | |
| DK0755517T3 (da) | Fremgangsmåde til detektion af tilstedeværelse af en Mycobacterium-art og et kit og antistoffer til anvendelse i denne | |
| Bes et al. | Hepatitis C virus (HCV)‐specific T‐cell responses among recombinant immunoblot assay‐3–indeterminate blood donors: a confirmatory evidence of HCV exposure | |
| EP1590671A1 (en) | Improved method of detection of hcv antibodies in combination assay or sole antibody assay | |
| Montebugnoli et al. | A rapid test for the visual detection of anti-hepatitis C virus antibodies in whole blood | |
| Karamitros et al. | Detection of specific antibodies to HCV‐ARF/CORE+ 1 protein in patients treated with pegylated interferon plus ribavirin | |
| Siman-Tov et al. | The use of epitope arrays in immunodiagnosis of infectious disease: hepatitis C virus, a case study | |
| El Awady et al. | Synthetic peptide-based immunoassay as a supplemental test for HCV infection | |
| Salminen et al. | Anti-HCV immunoassays based on a multiepitope antigen and fluorescent lanthanide chelate reporters | |
| La Montagne et al. | Severe acute respiratory syndrome: developing a research response | |
| CN101975857B (zh) | 病毒解裂剂及解裂病毒抗原抗体复合物并检测hcv抗原的方法 | |
| Igiri et al. | Diversity in typhoid diagnostic protocols and recommendation for composite reference standard | |
| DE69830174D1 (de) | Antikörper und sonstige bindungsmoleküle gegen hepatitis b virusantigene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A E 7A ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1942 25 - 03 - 2008. |